Is HUN a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Pending Olin merger, with revenue (ttm) at ~$5.9B. The bear case rests on huntsman is deeply cyclical and was loss-making in 2025 and on a trailing basis into 2026 (trailing net loss about $168 million), with about $2.5 billion of debt and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. Analysts covering it are spread from $9.00 to $14.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Huntsman is deeply cyclical and was loss-making in 2025 and on a trailing basis into 2026 (trailing net loss about $168 million), with about $2.5 billion of debt and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $9.00, +4.9% from the $8.58 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Pending Olin merger. In June 2026 Huntsman agreed to an all-stock merger of equals with Olin, with Huntsman holders set to receive about 0.5476 Olin shares per Huntsman share and to own roughly 45.5 percent of the combined 'OlinHuntsman.' The deal is pitched as creating a vertically integrated North American chemicals leader with more than $12 billion of revenue and over $400 million of targeted cost synergies. The most optimistic analyst target on HUN is $14.00, +63.2% from the $8.58 price. That figure is only reachable if this thesis works close to its best case.

Huntsman is deeply cyclical and was loss-making in 2025 and on a trailing basis into 2026 (trailing net loss about $168 million), with about $2.5 billion of debt and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. The dividend was reduced sharply, and the current annual rate of about $0.35 equals roughly 188% of earnings on Yahoo's payout measure, so it is not guaranteed. The Olin merger introduces deal risk: shareholder votes and US antitrust review are done, but other regulatory approvals remain and could delay or block it, and because it is all-stock the value received depends on Olin's share price. Low-cost Chinese MDI capacity, weak construction and automotive demand, and volatile feedstock costs such as benzene and European natural gas can all pressure margins further. The most pessimistic published target is $9.00, +4.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals organized into three segments: Polyurethanes (MDI, polyols and TPU used in insulation, autom

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Pending Olin merger) stalling in the reported numbers rather than in the narrative, the risk above (huntsman is deeply cyclical and was loss-making in 2025 and on a trailing basis into 2026 (trailing net loss about $168 million), with about $2.5 billion of debt and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Huntsman manufactures differentiated and specialty chemicals across three segments: Polyurethanes (MDI, polyols, TPU), Performance Products (amines, surfactants, maleic anhydride) and Advanced Materials (epoxy and other formulations). Its products go into insulation, automotive, adhesives, coatings, aerospace, agriculture and construction.

In June 2026 Huntsman agreed to an all-stock merger of equals with Olin Corporation. Huntsman holders would receive about 0.5476 Olin shares per share and own roughly 45.5 percent of the combined company, to be called OlinHuntsman. Shareholders of both companies approved the deal on August 25, 2026, and the US Hart-Scott-Rodino waiting period has expired; additional regulatory approvals are still underway before closing.

A deep chemicals downcycle has hit Huntsman, with weak construction, automotive, aerospace and electronics demand, lower MDI margins, and low-cost Chinese capacity pressuring prices. FY2025 revenue fell to about $5.7 billion and it posted a net loss of roughly $284 million. Losses narrowed in 2026, with adjusted EPS of about break-even in Q2, but the trailing twelve months still show a net loss near $168 million.